ABPRO HOLDINGS, INC.

Highlights Abpro Holdings, Inc.

Equities

ABPO

US0008472021

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 18:51:08 16/03/2026 GMT			5-day change	1st Jan Change
0.1180 ^USD	-3.28%		+18.00%	-97.21%

02-25	Abpro Holdings, Inc.(NasdaqCM:ABP) dropped from S&P TMI Index	CI
02-19	Abpro Holdings, Inc.(OTCPK:ABPO) dropped from NASDAQ Composite Index	CI

Highlights

01-06	Abpro Holdings, Inc. and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72	CI
12-15	Abpro Holdings, Inc. and Celltrion, Inc. Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T Cell Engager ABP-102/CT-P72 for HER2-Positive Cancers	CI
11-14	Abpro Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-07	Abpro Holdings files prospectus related to the offer and resale of up to 9.78 million shares of common stock - SEC filing	RE
22/10/25	Abpro Holdings Inc - to effect one-for-thirty reverse stock split - SEC filing	RE
13/08/25	Abpro Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Abpro Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
27/04/25	Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager	CI
15/04/25	Abpro Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/11/24	Abpro Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
12/11/24	Abpro Corporation completed the acquisition of Atlantic Coastal Acquisition Corp. II from Atlantic Coastal Acquisition Management II LLC and others in a reverse merger transaction.	CI
09/10/24	Abpro Holdings, Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW